Skip to main content
NCBI home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1988 Dec;26(12):2544–2548. doi: 10.1128/jcm.26.12.2544-2548.1988

Selective medium for Branhamella catarrhalis with acetazolamide as a specific inhibitor of Neisseria spp.

M Vaneechoutte 1, G Verschraegen 1, G Claeys 1, A M van den Abeele 1
PMCID: PMC266942  PMID: 3147992

Abstract

Several semiselective media for Branhamella catarrhalis have been proposed. These media allow growth of all members of the family Neisseriaceae, and further differentiation is necessary. By addition of 10 micrograms of acetazolamide, a carbonic anhydrase inhibitor, per ml and incubation in air, a medium was created which reduced growth of Neisseria spp. When saliva samples from 178 healthy schoolchildren were screened for the presence of B. catarrhalis, the carrier rate for this organism was estimated to be 48.9% with the selective medium compared with 12.4% when a semiselective medium, which contains only 10 micrograms of vancomycin, 5 micrograms of trimethoprim, and 2 micrograms of amphotericin B per ml, was used and 6.2% when a nonselective blood agar plate was used. The number of Neisseria spp. isolated dropped from 297 on the semiselective agar to 55 on the selective agar.

Full text

PDF
2544

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahmad F., McLeod D. T., Power J. T., Calder M. A. Branhamella catarrhalis prevalence in a hospital population. J Hosp Infect. 1985 Mar;6(1):71–74. doi: 10.1016/s0195-6701(85)80020-7. [DOI] [PubMed] [Google Scholar]
  2. Axelsson A., Brorson J. E. The correlation between bacteriological findings in the nose and maxillary sinus in acute maxillary sinusitis. Laryngoscope. 1973 Dec;83(12):2003–2011. doi: 10.1288/00005537-197312000-00011. [DOI] [PubMed] [Google Scholar]
  3. BERGER U., PAEPCKE E. [Studies on asaccharolytic Neisseria in the human nasopharynx]. Z Hyg Infektionskr. 1962;148:269–281. [PubMed] [Google Scholar]
  4. Berger U., Issi R. Resistenz gegen Acetazolamid als taxonomische Kriterium bei Neisseria. Arch Hyg Bakteriol. 1971 Apr;154(5):540–544. [PubMed] [Google Scholar]
  5. Brorson J. E., Axelsson A., Holm S. E. Studies on Branhamella Catarrhalis (Neisseria catarrhalis) with special reference to maxillary sinusitis. Scand J Infect Dis. 1976;8(3):151–155. doi: 10.3109/inf.1976.8.issue-3.05. [DOI] [PubMed] [Google Scholar]
  6. Brorson J. E., Malmvall B. E. Branhamella catarrhalis and other bacteria in the nasopharynx of children with longstanding cough. Scand J Infect Dis. 1981;13(2):111–113. doi: 10.3109/inf.1981.13.issue-2.06. [DOI] [PubMed] [Google Scholar]
  7. Christensen J. J., Gadeberg O., Bruun B. Branhamella catarrhalis: significance in pulmonary infections and bacteriological features. Acta Pathol Microbiol Immunol Scand B. 1986 Apr;94(2):89–95. doi: 10.1111/j.1699-0463.1986.tb03025.x. [DOI] [PubMed] [Google Scholar]
  8. Corkill J. E., Makin T. A selective medium for non-pathogenic aerobic Gram negative cocci from the respiratory tract: with particular reference to Branhamella catarrhalis. Med Lab Sci. 1982 Jan;39(1):3–10. [PubMed] [Google Scholar]
  9. Damani N. N., Chin A. T. Branhamella catarrhalis peritonitis in a continuous ambulatory peritoneal dialysis patient. Nephron. 1987;45(2):160–161. doi: 10.1159/000184102. [DOI] [PubMed] [Google Scholar]
  10. Davies B. I., Maesen F. P. Branhamella catarrhalis chest infections. Lancet. 1986 Aug 2;2(8501):278–278. doi: 10.1016/s0140-6736(86)92088-x. [DOI] [PubMed] [Google Scholar]
  11. Doern G. V., Gantz N. M. Isolation of Branhamella (Neisseria) catarrhalis from men with urethritis. Sex Transm Dis. 1982 Oct-Dec;9(4):202–204. doi: 10.1097/00007435-198210000-00008. [DOI] [PubMed] [Google Scholar]
  12. Doern G. V., Miller M. J., Winn R. E. Branhamella (Neisseria) catarrhalis systemic disease in humans. Case reports and review of the literature. Arch Intern Med. 1981 Nov;141(12):1690–1692. [PubMed] [Google Scholar]
  13. Forkman A., Laurell A. B. The effect of carbonic anhydrase inhibitor on the growth of Neisseriae. Acta Pathol Microbiol Scand. 1965;65(3):450–456. doi: 10.1111/apm.1965.65.3.450. [DOI] [PubMed] [Google Scholar]
  14. Garvey R. J., Reed T. A. Ophthalmia neonatorum due to Branhamella (Neisseria) catarrhalis. Case reports. Br J Vener Dis. 1981 Oct;57(5):346–347. doi: 10.1136/sti.57.5.346. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Heidemann D. G., Alfonso E., Forster R. K., Ullman S., Holland S. P., Mendelsohn A., Miller D. Branhamella catarrhalis keratitis. Am J Ophthalmol. 1987 Apr 15;103(4):576–581. doi: 10.1016/s0002-9394(14)74282-5. [DOI] [PubMed] [Google Scholar]
  16. Kamme C. Evaluation of the in vitro sensitivity of Neisseria catarrhalis to antibiotics with respect to acute otitis media. Scand J Infect Dis. 1970;2(2):117–120. doi: 10.3109/inf.1970.2.issue-2.07. [DOI] [PubMed] [Google Scholar]
  17. Knapp J. S., Hook E. W., 3rd Prevalence and persistence of Neisseria cinerea and other Neisseria spp. in adults. J Clin Microbiol. 1988 May;26(5):896–900. doi: 10.1128/jcm.26.5.896-900.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Kovatch A. L., Wald E. R., Michaels R. H. beta-Lactamase-producing Branhamella catarrhalis causing otitis media in children. J Pediatr. 1983 Feb;102(2):261–264. doi: 10.1016/s0022-3476(83)80537-x. [DOI] [PubMed] [Google Scholar]
  19. Leinonen M., Luotonen J., Herva E., Valkonen K., Mäkelä P. H. Preliminary serologic evidence for a pathogenic role of Branhamella catarrhalis. J Infect Dis. 1981 Dec;144(6):570–574. doi: 10.1093/infdis/144.6.570. [DOI] [PubMed] [Google Scholar]
  20. Pollard J. A., Wallace R. J., Jr, Nash D. R., Luman J. I., Wilson R. W. Incidence of Branhamella catarrhalis in the sputa of patients with chronic lung disease. Drugs. 1986;31 (Suppl 3):103–108. doi: 10.2165/00003495-198600313-00022. [DOI] [PubMed] [Google Scholar]
  21. Prellner K., Christensen P., Hovelius B., Rosén C. Nasopharyngeal carriage of bacteria in otitis-prone and non-otitis-prone children in day-care centres. Acta Otolaryngol. 1984 Sep-Oct;98(3-4):343–350. doi: 10.3109/00016488409107572. [DOI] [PubMed] [Google Scholar]
  22. Righter J., Nicol G. Branhamella catarrhalis conjunctivitis. Can Med Assoc J. 1983 Apr 15;128(8):955–956. [PMC free article] [PubMed] [Google Scholar]
  23. Sanders E., Maren T. H. Inhibition of carbonic anhydrase in Neisseria: effects on enzyme activity and growth. Mol Pharmacol. 1967 Mar;3(2):204–215. [PubMed] [Google Scholar]
  24. Schalén L., Christensen P., Kamme C., Miörner H., Pettersson K. I., Schalén C. High isolation rate of Branhamella catarrhalis from the nasopharynx in adults with acute laryngitis. Scand J Infect Dis. 1980;12(4):277–280. doi: 10.3109/inf.1980.12.issue-4.07. [DOI] [PubMed] [Google Scholar]
  25. Schreiner A., Bjerkestrand G., Digranes A., Halvorsen F. J., Kommedal T. M. Bacteriological findings in the transtracheal aspirate from patients with acute exacerbation of chronic bronchitis. Infection. 1978;6(2):54–56. doi: 10.1007/BF01642158. [DOI] [PubMed] [Google Scholar]
  26. Smith J. M., Lockwood B. M. A 2-year survey of Branhamella catarrhalis in a general hospital. J Hosp Infect. 1986 May;7(3):277–282. doi: 10.1016/0195-6701(86)90078-2. [DOI] [PubMed] [Google Scholar]
  27. Soto-Hernandez J. L., Nunley D., Holtsclaw-Berk S., Berk S. L. Selective medium with DNase test agar and a modified toluidine blue O technique for primary isolation of Branhamella catarrhalis in sputum. J Clin Microbiol. 1988 Mar;26(3):405–408. doi: 10.1128/jcm.26.3.405-408.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Thayer J. D., Martin J. E., Jr Improved medium selective for cultivation of N. gonorrhoeae and N. meningitidis. Public Health Rep. 1966 Jun;81(6):559–562. [PMC free article] [PubMed] [Google Scholar]
  29. VEITCH F. P., BLANKENSHIP L. C. Carbonic anhydrase in bacteria. Nature. 1963 Jan 5;197:76–77. doi: 10.1038/197076a0. [DOI] [PubMed] [Google Scholar]
  30. Van Hare G. F., Shurin P. A., Marchant C. D., Cartelli N. A., Johnson C. E., Fulton D., Carlin S., Kim C. H. Acute otitis media caused by Branhamella catarrhalis: biology and therapy. Rev Infect Dis. 1987 Jan-Feb;9(1):16–27. doi: 10.1093/clinids/9.1.16. [DOI] [PubMed] [Google Scholar]
  31. Vaneechoutte M., Verschraegen G., Claeys G., Flamen P. Rapid identification of Branhamella catarrhalis with 4-methylumbelliferyl butyrate. J Clin Microbiol. 1988 Jun;26(6):1227–1228. doi: 10.1128/jcm.26.6.1227-1228.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Wallace R. J., Jr, Musher D. M. In honor of Dr. Sarah Branham, a star is born. The realization of Branhamella catarrhalis as a respiratory pathogen. Chest. 1986 Sep;90(3):447–450. doi: 10.1378/chest.90.3.447. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES